Fluoroquinolone Resistance and Clostridium difficile , Germany
Authors:
- Nils Henning ZaißNZNils Henning Zaiß
- Wolfgang WitteWWWolfgang Witte
- Ulrich NübelUNUlrich Nübel
Open Access
- 1 April 2010
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 16 (4) , 675-677
Abstract
We characterized 670 Clostridium difficile isolates collected from patients in 84 hospitals in Germany in 2008. PCR ribotyping showed high prevalence of ribotype 001 and restricted dissemination of ribotype 027 strains. Fluoroquinolone resistance and associated gyrase mutations were frequent in various ribotypes, but no resistance to metronidazole or vancomycin was noted.Keywords
This publication has 15 references indexed in Scilit:
- Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the NetherlandsEurosurveillance, 2009
- Typing Clostridium difficile strains based on tandem repeat sequencesBMC Microbiology, 2009
- Clostridium difficileInfections in a Canadian Tertiary Care Hospital before and during a Regional Epidemic Associated with the BI/NAP1/027 StrainAntimicrobial Agents and Chemotherapy, 2008
- Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in EuropeJournal of Medical Microbiology, 2008
- Clostridium difficile in Discharged Inpatients, GermanyEmerging Infectious Diseases, 2007
- Emergence of Clostridium difficile-associated disease in North America and EuropeClinical Microbiology and Infection, 2006
- Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in QuebecClinical Infectious Diseases, 2005
- gyrA and gyrB Mutations Are Implicated in Cross-Resistance to Ciprofloxacin and Moxifloxacin in Clostridium difficileAntimicrobial Agents and Chemotherapy, 2002
- Resistance to Moxifloxacin in Toxigenic Clostridium difficile Isolates Is Associated with Mutations in gyrAAntimicrobial Agents and Chemotherapy, 2001
- Mechanisms of fluoroquinolone resistanceDrug Resistance Updates, 1999